In the period from July 1st, 2019 to December 31st, 2019, Stemmer Imaging generated sales of €62.3 million. (previous year: €50.7 million). Total growth was 22.8% with the first-time consolidation of the Infaimon Group. Despite a declining overall market (VDMA: -8% for 2019), Stemmer achieved organic growth of 0.4% in the short financial year 2019, particularly due to growth in end markets such as Sports & Entertainment, Food & Agriculture and Healthcare. The adjusted Group Ebitda amounts to around €4.8 million (previous year €4.0 million).
Chromasens has introduced a 3D inspection system designed for detecting imperfections on the surface of metal cylinder heads requiring large field of views.